26 sessions available

Friday August 15

8:30 AM - 9:30 AM
break

Breakfast

Welcome breakfast for all attendees.

⏱️ 28 days0
9:30 AM - 9:45 AM
keynote

Official Opening and Welcome

⏱️ 28 days0
10:00 AM - 10:30 AM
keynote

Keynote: Advancements and Advocacy in the Management of Sickle Cell Disease

  • Evaluate recent clinical advancements in SCD therapies and their integration into medical practice.
  • Interpret the impact of advocacy on clinical guidelines and patient access to care.
  • Identify emerging challenges in disease management and propose clinician-driven policy improvements
⏱️ 28 days0
10:35 AM - 11:35 AM
session

Plenary: Ontario Health: An Update on the Implementation of the Quality Standards for Sickle Cell Disease

Update on the Ontario Health Quality Standards in Health Systems Change The State of Emergency and Impatient Care in Canadian Hospitals – Where things need to improve.

  • Assess the system-level implementation of Ontario’s SCD Quality Standards.
  • Design dashboards and data systems for ongoing monitoring.
  • Lead change initiatives to close performance gaps at the institutional level.
⏱️ 28 days0
11:40 AM - 12:00 PM
break

Morning Break

⏱️ 28 days0
12:00 PM - 12:30 PM
session

Oral Abstract Presentation

Presentation of selected research abstracts.

⏱️ 28 days0
12:35 PM - 1:35 PM
lunch

Lunch / Poster Presentation

Networking lunch with poster presentations.

⏱️ 28 days0
1:40 PM - 2:40 PM
session

Sickle Cell: What every patient and parent needs to know about sickle cell disease

Concurrent session for patients and parents.

  • Develop accessible educational materials that align with clinical needs.
  • Collaborate with clinicians to improve understanding of available therapies.
  • Support digital tools and platforms that enhance patient education.
  • +2 more topics...
⏱️ 28 days0
1:40 PM - 2:40 PM
session

Best Practices in Prescribing Disease Modifying Therapies in SCD

Concurrent session for providers.

  • Support policies that promote equity in blood donation recruitment and access.
  • Collaborate with community organizations to improve donor diversity.
  • Monitor equity metrics in transfusion practices.
⏱️ 28 days0
2:45 PM - 3:45 PM
session

Equity and Inclusion in Blood Donation

Concurrent session for patients.

  • Opportunities and challenges to engage Community in Blood Donations
  • Efforts in blood donation in Atlantic Provinces"
  • What the Canadian Blood Services is Doing Differently to serve the Sickle Cell Community
⏱️ 28 days0
2:45 PM - 3:45 PM
session

Alloimmunization and Hyperhemolysis in SCD

Concurrent session for providers.

  • Identify patients at high risk for alloimmunization and hyperhemolysis.
  • Apply transfusion protocols that reduce immunologic complications.
  • Manage acute hyperhemolysis episodes using current clinical guidelines.
⏱️ 28 days0
3:45 PM - 4:00 PM
break

Break

A short break for networking.

⏱️ 28 days0
4:00 PM - 5:00 PM
session

Comprehensive Models of Sickle Cell Disease Care

Plenary session on models of care.

  • Design and fund integrated care models for SCD.
  • Align care models with provincial or national standards.
  • Measure the cost-effectiveness and patient outcomes of models.
⏱️ 28 days0

Saturday August 16th

8:30 AM - 9:30 AM
break

Breakfast

Morning breakfast for all attendees.

⏱️ 29 days0
9:35 AM - 9:45 AM
keynote

Welcome Remarks

⏱️ 29 days0
9:45 AM - 10:15 AM
keynote

Keynote: Creating a Connected World to Improve Sickle Cell Care

Creating a Connected World to Improve Sickle Cell Care - Registries, Community of Practice and other strategies to advance sickle cell care

  • Describe the clinical utility of national and international SCD registries in improving care outcomes.
  • Engage in communities of practice to share data and refine clinical decision-making.
  • Identify how integrated systems improve care continuity and patient monitoring.
⏱️ 29 days0
10:20 AM - 11:20 AM
session

Health Care Providers and Community as Partners in Advancing SCD Care and Treatment

Plenary session on partnerships in care.

  • Develop frameworks that support community-clinical partnerships in SCD care.
  • Allocate resources to programs co-designed with patients and families.
  • Measure the impact of community engagement on patient retention and outcomes.
⏱️ 29 days0
11:25 AM - 11:40 AM
break

Break

A short break for networking.

⏱️ 29 days0
11:40 AM - 12:40 PM
session

Future Innovation in Patient Pain Management for Sickle Cell Disease

Concurrent session for patients.

  • Evaluate emerging pharmacologic and non-pharmacologic innovations in pain management for SCD.
  • Investigate novel therapies and integrative approaches for managing pain in SCD.
  • Collaborate with interdisciplinary teams to implement evidence-based, patient-centred pain protocols.
⏱️ 29 days0
11:40 AM - 12:40 PM
session

What's Hot in Cell and Gene Therapy: Which Should I recommend and when?

Concurrent session for providers.

  • Educate providers on eligibility and patient selection for new therapies.
  • Provide clinical support tools to assist in therapy recommendation decisions.
  • Support post-marketing research on safety and efficacy.
⏱️ 29 days0
12:45 PM - 1:00 PM
session

Oral Abstract Presentation

Presentation of selected research abstracts.

⏱️ 29 days0
1:00 PM - 2:00 PM
lunch

Lunch / Poster Presentations

Networking lunch with poster presentations.

⏱️ 29 days0
2:00 PM - 3:00 PM
session

Transitioning Across the Life Span

Concurrent session for patients.

  • Educate adolescents and families on self-advocacy and disease management.
  • Coordinate care during periods of transition to reduce loss to follow-up.
  • Monitor emotional well-being throughout the transition process.
⏱️ 29 days0
2:00 PM - 3:00 PM
session

Acute Chest Syndrome and Pulmonary Hypertension – How to spot it and the best way to treat it

Concurrent session for providers.

  • Recognize early clinical and radiologic signs of acute chest syndrome and PH.
  • Initiate appropriate acute and long-term management strategies.
  • Evaluate patients for PH risk and refer for specialized care as needed.
⏱️ 29 days0
3:05 PM - 4:05 PM
session

Genetic Screening for Inherited Blood Disorders and Sickle Cell Trait in Canada

Plenary session on genetic screening.

  • Design or support provincial screening programs aligned with national policy.
  • Ensure equity in access to genetic counseling and follow-up services.
  • Monitor program effectiveness and community engagement.
⏱️ 29 days0
4:10 PM - 4:15 PM
keynote

Closing Remarks

Closing remarks for the summit.

⏱️ 29 days0

August 15-16th, 2025

Sheraton Toronto Airport Hotel & Conference Centre

Quick Links

Contact

Address: 330-5109 Steeles Ave W.
North York, ON , M9L 2Y8


Phone: GTA: 416-745-4267


Email: info@sicklecellanemia.ca

Got a Question?

Want to Support Us?

© SCAGO - All Rights Reserved -Disclaimer - Charitable Registration #: 83332 0872 RR 0001

Quick Links

Contact

Address: 330-5109 Steeles Ave W.

North York, ON M9L 2Y8


Phone: 416-745-4267


Email: info@sicklecellanemia.ca

Got a Question?

Want to Support Us?

© SCAGO - All Rights Reserved -Disclaimer - Charitable Registration #: 83332 0872 RR 0001

Contact

Address: 330-5109 Steeles Ave W.
North York, ON M9L 2Y8


Phone: 416-745-4267


Email: info@sicklecellanemia.ca

Got a Question?

Want to Support Us?

© SCAGO - All Rights Reserved -Disclaimer - Charitable Registration #: 83332 0872 RR 0001